Cardium Therapeutics, Inc. (CXM) Announces U.S. Intro of Excellagen
Friday, Cardium Therapeutics announced Excellagen’s introduction into U.S. markets. Excellagen is a wound care product for dermal wounds, such as diabetic foot ulcers and other types of pressure ulcers. Cardium is focused on the acquisition and development of new bio-medical products. Currently, the company's portfolio, centered on health sciences and regenerative medicine, includes Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform. The company is also developing Generx, a product intended for the treatment of patients with myocardial ischemia due to coronary artery disease. Excellagen is a syringe-based topical wound care product and…